human recombinant bone morphogenetic protein 4

human recombinant bone morphogenetic protein 4
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2016-05-04 00:00:00
Sponsor HyperStem Therapeutics, Inc.;13223-1 Black Mountain Road;San Diego, California, 92129
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM